Effects of Vitamin D Receptor Activation and Dietary Sodium Restriction on Residual Albuminuria in CKD: The ViRTUE-CKD Trial.
about
Public health relevance of drug-nutrition interactions.Biomarkers of Renal Function: Towards Clinical Actionability.Vitamin D receptor: A novel therapeutic target for kidney diseases.Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention.Low Sodium Diet, Vitamin D, or Both for RAASi-Resistant, Residual, Proteinuria in CKD? The ViRTUE Trial Points the Way Forward but Is Not the Last Word.Dietary Salt Restriction in Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials.
P2860
Effects of Vitamin D Receptor Activation and Dietary Sodium Restriction on Residual Albuminuria in CKD: The ViRTUE-CKD Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Effects of Vitamin D Receptor ...... in CKD: The ViRTUE-CKD Trial.
@en
Effects of Vitamin D Receptor ...... in CKD: The ViRTUE-CKD Trial.
@nl
type
label
Effects of Vitamin D Receptor ...... in CKD: The ViRTUE-CKD Trial.
@en
Effects of Vitamin D Receptor ...... in CKD: The ViRTUE-CKD Trial.
@nl
prefLabel
Effects of Vitamin D Receptor ...... in CKD: The ViRTUE-CKD Trial.
@en
Effects of Vitamin D Receptor ...... in CKD: The ViRTUE-CKD Trial.
@nl
P2093
P2860
P356
P1476
Effects of Vitamin D Receptor ...... in CKD: The ViRTUE-CKD Trial.
@en
P2093
Arjan J Kwakernaak
Charlotte A Keyzer
G Fenna van Breda
Gerjan Navis
Gozewijn D Laverman
Hiddo J Lambers Heerspink
Holland Nephrology Study (HONEST) Network
Maarten A de Jong
Marc G Vervloet
Marc H Hemmelder
P2860
P304
P356
10.1681/ASN.2016040407
P577
2016-11-17T00:00:00Z